FactoryRegistry
Claim a page

Manufacturing of hypotensives, including rauwolfia-alkaloid preparations and beta receptor blocking agents

3,188 FACILITIES
FacilityCityStateEmployeesStatus
Thermo Fisher ScientificRidgefieldNJ— UNVERIFIED
Thermo Fisher ScientificPleasantonCA— UNVERIFIED
Thermo Fisher ScientificManatiPR— UNVERIFIED
Thermo Fisher ScientificBendOR— UNVERIFIED
The Sobrato Organization LLCSan FranciscoCA— UNVERIFIED
Thornhill Therapeutics INCSouth San FranciscoCA— UNVERIFIED
three nations Corp.MediaPA— UNVERIFIED
Tiger Aesthetics MedicalSan DiegoCA— UNVERIFIED
Tishcon CorporationWestburyNY— UNVERIFIED
Tizona Therapeutics INCBrisbaneCA— UNVERIFIED
Tizona Theraputics INCSouth San FranciscoCA— UNVERIFIED
Tolmar INCNorth ChicagoIL— UNVERIFIED
Tolmar INCNorthbrookIL— UNVERIFIED
Tolmar INCWindsorCO— UNVERIFIED
Topos Bio INCSouth San FranciscoCA— UNVERIFIED
Trace NeuroscienceSouth San FranciscoCA— UNVERIFIED
Transgenomic INCOmahaNE— UNVERIFIED
Translate Bio INCBurlingtonMA— UNVERIFIED
Trefoil Therapeutics INCSan DiegoCA— UNVERIFIED
Trigen LaboratoriesSalisburyMD— UNVERIFIED
Trilink BiotechnologiesSan DiegoCA— UNVERIFIED
Trilink Biotechnologies, INCSan DiegoCA— UNVERIFIED
Trilo TherapeuticsSan FranciscoCA— UNVERIFIED
Trinh Vu Md INCStocktonCA— UNVERIFIED
Tripharm Services, INC - Suite 100 (dba Alcami)MorrisvilleNC— UNVERIFIED

FactoryRegistry lists 3,188 facilities whose primary industry classification is one of the 1 industry above. This is a list by industry, not a list of makers: Census reports that establishments in these industries produced hypotensives, including rauwolfia-alkaloid preparations and beta receptor blocking agents, in the shares shown above, and does not say which establishments. Where a plant’s own website or a federal registry names what that plant makes, it appears on the plant’s own page with the source named.

The U.S. Census Bureau recorded this product line in 1 US manufacturing industry in the 2022 Economic Census, as the most specific line that industry reported, where 51 establishments reported producing it.

These are counts of establishments by industry: the Economic Census publishes them as industry totals and never as a list of plants.

Related lines
Manufacturing of pharmaceutical preparations, acting on skin, for human use, including burn remedies, antiacne preparations, antiseborrheic preparations, resorcinol preparations, hemorrhoidal preparations, and external ointments and creamsManufacturing of pharmaceutical preparations, acting on the digestive or the genito-urinary systems, for human use, including antacids and antidiarrheals, laxatives, antinauseants, urinary antibacterials, oxytocics, diuretics, contraceptive agents, and prManufacturing of anticoagulants, hemostatics, and digitalis preparationsManufacturing of other pharmaceutical preparations, acting on the cardiovascular system, including vasopressors and anti-heparin agents, for human useManufacturing of pharmaceutical preparations, acting on the respiratory system, for human use, including antihistamines, nasal sprays and drops, cough drops, cough and cold preparations, and beta-agonists, prescription and non-prescriptionManufacturing of vasodilators, ace inhibitorsManufacturing of vasodilators, anti-arrythmicsManufacturing of vasodilators, calcium channel blockersManufacturing of vasodilators, coronary and peripheral
Industries
Chemical ManufacturersAll product lines

NAPCS collection code 2010200006. Source for the product line, the establishment counts and the shares: U.S. Census Bureau, 2022 Economic Census (ECNNAPCSIND2022). Federal source data is public domain. Facility records are compiled separately by FactoryRegistry and carry their own sources.